Anaplastic Lymphoma Kinase Receptor: Possible Involvement in Anorexia Nervosa

Simona Dedoni1, Maria Scherma1, Chiara Camoglio1

  • 1Section of Neuroscience and Clinical Pharmacology, Department of Biomedical Science, University of Cagliari, 09124 Cagliari, Italy.

Nutrients
|July 11, 2023
PubMed

Insights

Anaplastic lymphoma kinase (ALK) receptor expression decreases in rats with activity-based anorexia, suggesting its role in anorexia nervosa pathophysiology and potentially influencing weight regulation.

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Endocrinology

Background:

  • The pathophysiology of Anorexia Nervosa (AN) remains incompletely understood.
  • Anaplastic lymphoma kinase (ALK) is a protein-tyrosine kinase primarily recognized for its oncogenic role.
  • Recent studies suggest ALK influences energy expenditure and obesity resistance, hinting at a role in thinness regulation.

Purpose of the Study:

  • To investigate the expression of ALK and its downstream signaling pathways in a rat model of activity-based anorexia (ABA).
  • To explore the potential involvement of ALK in the mechanisms underlying AN.

Main Methods:

  • Utilized the activity-based anorexia (ABA) rat model, which mimics key features of human AN.
  • Analyzed hypothalamic tissue lysates from ABA rats to assess ALK receptor expression and phosphorylation of downstream kinases Akt and ERK1/2.
  • Examined changes in ALK expression during ABA induction and subsequent recovery.

Main Results:

  • ABA rats exhibited reduced hypothalamic ALK receptor expression and decreased Akt phosphorylation compared to controls.
  • Extracellular signal-regulated protein kinases 1 and 2 (ERK1/2) phosphorylation levels remained unchanged.
  • Following recovery from weight loss, ALK expression normalized, but decreased again upon re-induction of ABA.

Conclusions:

  • Evidence suggests a potential role for the ALK receptor in the pathophysiology of Anorexia Nervosa.
  • ALK may be implicated in the stabilization, resistance, or exacerbation of AN.
  • Further research into ALK signaling could reveal novel therapeutic targets for AN.

Related Concept Videos

Anorexia Nervosa01:28

Anorexia Nervosa

Anorexia nervosa is a complex and severe eating disorder characterized by an intense fear of weight gain, an unrelenting pursuit of thinness, and a distorted body image. It often leads to dangerously low body weight relative to an individual's age and height. This disorder is marked by significant physical and psychological consequences, making it one of the most life-threatening psychiatric illnesses.
Symptoms and Physical Effects
Individuals with anorexia nervosa commonly exhibit extreme...
150
Bulimia Nervosa01:30

Bulimia Nervosa

Bulimia nervosa is a complex and severe eating disorder characterized by a cyclical pattern of binge-and-purge eating pattern. It generally involves an episode of binge eating, followed by compensatory behaviors such as vomiting, excessive exercise, laxative use, or fasting, to prevent weight gain. Despite often maintaining a normal weight, individuals with bulimia are intensely preoccupied with their body image and harbor an overwhelming fear of gaining weight. This can contribute to the...
163
Regulation of Food Intake01:30

Regulation of Food Intake

Short-term regulation of food intake primarily involves neural signals from the gastrointestinal (GI) tract, blood nutrient levels, and GI tract hormones. Communication between the gut and brain via vagal nerve fibers plays a significant role in evaluating the contents of the gut. Clinical studies have shown that protein ingestion produces a more prolonged response in these nerve fibers compared to an equivalent amount of glucose. Additionally, the activation of stretch receptors caused by GI...
288
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.8K
Binge Eating Disorders01:23

Binge Eating Disorders

Binge eating disorder is a significant mental health condition characterized by recurrent episodes of excessive food consumption within a short period, accompanied by a perceived loss of control over eating behavior. Unlike occasional overeating, binge eating disorder is marked by distressing emotions such as guilt, shame, and anxiety following binge episodes. The disorder affects individuals across different ages and backgrounds, with profound implications for physical and psychological...
146
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
3.7K